Our Obesity Amplicon Sequencing Panel targets 35 genes that were expertly selected based on their association with obesity. This assay is performed using genomic DNA isolated from human peripheral whole blood specimens.
The test is intended to identify the variants that are associated with obesity. It is performed as a pre-symptomatic genetic test in order to determine whether persons with a family history of obesity, but no current symptoms, has the gene alterations associated with the disease. The test can also be used for post-symptomatic genetic testing to confirm variants of association to obesity.
There is a direct correlation between increasing obesity and higher risk of health problems such as type 2 diabetes, coronary heart disease, hypertension, arthritis and even cancer. Unraveling the genetic background associated obesity may lead to more efficient ways to manage the obesity phenomenon and diseases associated with it.